bn:23805884n
Noun Named Entity
Categories: Orphan drugs, Antineoplastic and immunomodulating drug stubs, Engineered proteins, Cancer treatments
EN
tagraxofusp  tagraxofusp-erzs  Elzonris  SL-401
EN
Tagraxofusp, sold under the brand name Elzonris, is an anti-cancer medication for the treatment of blastic plasmacytoid dendritic cell neoplasm. Wikipedia
Definitions
Relations
Sources
EN
Tagraxofusp, sold under the brand name Elzonris, is an anti-cancer medication for the treatment of blastic plasmacytoid dendritic cell neoplasm. Wikipedia
Wikipedia
Wikidata
Wikipedia Redirections
Wikidata Alias